Sexual Dysfunction in Hypertensive Women

Summary

Several studies describe the existence of an association between sexual dysfunction and high blood pressure (hypertension), most often characterized by a decrease in the number of orgasms and the existence of dyspareunia.

Hypertension is a contributing factor, and nonadherence to medication could amplify it.

There are several ways to assess adherence to treatment: the use of declarative questionnaires, a method not without criticism because it is subject to the subjectivity of the declaration by the patient; and drug dosages, a standard technique, although insufficiently disseminated due to the high cost and greater weight of the survey protocols. Drug non-compliance is multifactorial. In addition, it has been shown that having undesirable drug effects and / or being afraid of developing them is one of the major causes of non-compliance with antihypertensive treatments.

The investigators hypothesize that DS is significantly more common among hypertensive women treated with non-observers compared to hypertensive women treated with observers.

The main objective is to compare the prevalence of sexual dysfunction between a group of hypertensive women treated as observers and a group of hypertensive women treated as non-observers.

Conditions

• Hypertension

Interventions

BIOLOGICAL

Blood sample for the determination of antihypertensives or their metabolites.

15 ml of Blood sample for the determination of antihypertensives or their metabolites

BEHAVIORAL

Questionnaire on sexual activity

Questionnaire on sexual activity in women

BEHAVIORAL

Scale on hospital anxiety and depression

Scale on hospital anxiety and depression to detect anxious and depressive symptoms (14 questions)

BEHAVIORAL

Morisky Questionaire

anti-hypertensive medication compliance questionnaire

Sponsors & Collaborators

• University Hospital, Toulouse

  lead OTHER

Principal Investigators

• Delphine LAZARO-VERGE, MD · University Hospital, Toulouse

Study Design

Allocation

NA

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-06-27

Primary Completion

2026-07-07

Completion

2026-07-07

Countries

• France

Study Locations